article
Transforming Patient Support: More Patients, Better Outcomes, Maximum Brand Value
Leaders from Pfizer, SK Life Science, Ionis Pharmaceuticals, Neovance, and Stratis Group share perspectives on what the next-generation patient experience looks like.
Redi convened an Executive Roundtable with pharmaceutical company leaders from Pfizer, Ionis Pharmaceuticals, SK Life Science, Neovance, and Stratis Group. The experts share their insights and perspectives about transforming patient support programs (PSPs) into modern experiences that enroll patients early, improve engagement and therapy sustainment, and maximize brand value.
Read the Report to:
- Learn where the biggest opportunities exist to transform PSPs into next-generation patient experiences
- Discover what the next-generation patient experience is starting to look for pharmaceutical manufacturers and patients
- Gain insights into the opportunities that PSP transformation creates
- Understand what it takes to meaningfully transform PSPs
- Explore how data, AI, and automation are reshaping patient experiences